Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
03/15/2000 | CN1247075A Chinese patent medicine for treating piles |
03/15/2000 | CN1247073A Chinese medicine for treating acyesis |
03/15/2000 | CN1247065A Medicine for treating trigeminal neuralgia |
03/15/2000 | CN1050299C Decoction for lowering glucose in urine and quenching thirst |
03/15/2000 | CN1050298C Traditional Chinese medicine powder for bone-setting, and method for preparing same |
03/15/2000 | CN1050293C Ant compsn. preparation and its preparing method |
03/15/2000 | CN1050292C Anticancer drug and preparing method thereof |
03/15/2000 | CN1050290C External oil for man and woman |
03/15/2000 | CN1050289C Quick-acting antirheumatic medicine |
03/15/2000 | CN1050287C Medicine for treating infantile eczema and its preparing method |
03/14/2000 | US6037446 Gestational agents for controlling cell proliferation |
03/14/2000 | US6037175 Method and media for enhancing cryopreservation of cells |
03/14/2000 | US6037174 Preparation of serum-free suspensions of human hematopoietic cells or precursor cells |
03/14/2000 | US6036966 Topical skin exfolient with protein, enzyme albumin, abrasives and bactericides |
03/14/2000 | US6036952 Lactic acid bacteria inhibiting the formation of dental plaque in the mouth |
03/14/2000 | US6036951 Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders |
03/14/2000 | US6036950 Administering immunogenic preparation of cells |
03/14/2000 | US6036857 Apparatus for continuous magnetic separation of components from a mixture |
03/14/2000 | CA2143335C Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
03/14/2000 | CA2098483C Safe adeno-associated virus 2 vector for gene therapy |
03/09/2000 | WO2000012741A2 Inducible expression system |
03/09/2000 | WO2000012738A1 Targeted adenovirus vectors for delivery of heterologous genes |
03/09/2000 | WO2000012706A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
03/09/2000 | WO2000012686A1 Expression systems for functional nucleic acid expression |
03/09/2000 | WO2000012683A2 Stem cells bearing an fgf receptor on the cell surface |
03/09/2000 | WO2000012682A1 Primate embryonic stem cells with compatible histocompatibility genes |
03/09/2000 | WO2000012519A1 Phosphoepoxides, method for making same and uses |
03/09/2000 | WO2000012516A1 Phosphohalohydrins, method for making same and uses |
03/09/2000 | WO2000012138A2 Cells expressing immunoregulatory molecules and uses therefor |
03/09/2000 | WO2000012104A1 Homeopathic medicine comprising one or several mother-of-pearl constituents including bio-aragonite |
03/09/2000 | WO2000012103A1 Method for removal of hiv and other viruses from blood |
03/09/2000 | WO2000012102A1 Blended compositions for treatment of alzheimer's disease and other amyloidoses |
03/09/2000 | WO2000012079A1 Substances having antiobese and visceral fat-reducing functions and utilization thereof |
03/09/2000 | WO2000012066A1 Alginate capsules for use in the treatment of brain tumour |
03/09/2000 | WO2000012028A1 Implantable system with drug-eluting cells for on-demand local drug delivery |
03/09/2000 | WO2000011969A1 Method for obtaining avian biological products |
03/09/2000 | WO2000011946A2 Prolonged storage of red blood cells |
03/09/2000 | WO2000001348A3 A fibrin sealant from clotting factors in fish blood |
03/09/2000 | WO1999064570A9 Novel methods and interferon deficient substrates for the propagation of viruses |
03/09/2000 | WO1999064068A9 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
03/09/2000 | WO1999064024A3 Use of adeno-associated viruses for decreasing the radiotherapy-induced or chemotherapy-induced resistance in cancer patients |
03/09/2000 | WO1999061586A8 Promotion of cell differentiation by initially passaged cells |
03/09/2000 | WO1999053949A3 Combination of antigen pulsed apcs and interleukin 12 for tumor and viral therapy |
03/09/2000 | DE19838794A1 Zusammensetzung zur Behandlung von Osteoarthritis und zur nutritiven Behandlung des Gelenkknorpels Composition for the treatment of osteoarthritis and nutritional treatment of articular cartilage |
03/09/2000 | CA2352480A1 Homeopathic medicine comprising one or several mother-of-pearl constituents including bio-aragonite |
03/09/2000 | CA2342218A1 Substances having antiobese and visceral fat-reducing functions and utilization thereof |
03/09/2000 | CA2342205A1 Primate embryonic stem cells with compatible histocompatibility genes |
03/09/2000 | CA2341775A1 Inducible expression system |
03/09/2000 | CA2341755A1 Cells expressing immunoregulatory molecules and uses therefor |
03/09/2000 | CA2341754A1 Stem cells bearing an fgf receptor on the cell surface |
03/09/2000 | CA2341578A1 Phosphoepoxides, method for making same and uses |
03/09/2000 | CA2341061A1 Targeted adenovirus vectors for delivery of heterologous genes |
03/09/2000 | CA2340325A1 Alginate capsules for use in the treatment of brain tumour |
03/08/2000 | EP0984068A2 Sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
03/08/2000 | EP0984067A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
03/08/2000 | EP0983726A1 Amino acid-trehalose composition |
03/08/2000 | EP0983355A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33 |
03/08/2000 | EP0983354A2 Neurotrophic factor receptors |
03/08/2000 | EP0983353A1 Methods and compositions for diagnosis and treatment of cancer |
03/08/2000 | EP0983095A2 Peptide-coated implants and methods for producing same |
03/08/2000 | EP0983081A1 Transmucosal induction of tolerance to parenterally administered non-autologous polypeptides |
03/08/2000 | EP0983080A1 Synthetic, statistic thymus peptide combination and its use as a preparation with immunological and/or endocrinological effect |
03/08/2000 | EP0983077A1 Pharmaceutical composition and diagnostic kit directed to a heterologeneous pathogenic organism in a host |
03/08/2000 | EP0983076A1 Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease |
03/08/2000 | EP0983075A1 A method to increase the survival of transplanted cells |
03/08/2000 | EP0983074A2 Non-myeloablative tolerogenic treatment |
03/08/2000 | EP0983038A1 Novel powder compositions |
03/08/2000 | CN1246800A Infectious bursits vaccine |
03/08/2000 | CN1246778A Method and compositions for producing dried, storage-stable platelets |
03/08/2000 | CN1246368A Medicinal liquor for treating hyperlipemia and hyperviscosity blood |
03/08/2000 | CN1246362A Medicine for treating hyperosteogeny |
03/08/2000 | CN1246360A Preparation used for orthopedics and its preparing process |
03/08/2000 | CN1246357A Chinese patent medicine for treating epilepsy |
03/08/2000 | CN1246356A Fetus-protecting instant particles for treating habitual or threatened abortion |
03/08/2000 | CN1246346A Medicine for treating cancer and its preparing technology |
03/08/2000 | CN1246345A Medical liquor for nourishing kidney |
03/08/2000 | CN1246341A Health-care medicinal powder |
03/08/2000 | CN1246340A Medicinal powder for treating burn and scald |
03/08/2000 | CN1050133C Method for preparing glycan shell |
03/08/2000 | CN1050052C Habit-breaking acupoint adhesive plaster for smoke |
03/08/2000 | CN1050051C 'Dianjiankang'-Chinese patent drug for treatment of epilepsy |
03/08/2000 | CN1050048C Jiedufugugao Adhesive plaster for treating medullitis |
03/08/2000 | CN1050047C Chinese patent drug medicine for arresting bleeding and pulse restoring and its producing method |
03/08/2000 | CN1050046C Capsule for treating flaccid paralysis from apoplexy and its preparation method |
03/08/2000 | CN1050045C Traditional Chinese medicine for treating cancer of esophagus |
03/08/2000 | CN1050044C 'Sanhuanbunaodan' preparation method for treating encephalomyelophathy |
03/07/2000 | US6034124 Bactericides |
03/07/2000 | US6033908 Packaging systems for human recombinant adenovirus to be used in gene therapy |
03/07/2000 | US6033905 Gibbon ape leukemia virus-based retroviral vectors |
03/07/2000 | US6033888 Process for microencapsulating cells |
03/07/2000 | US6033885 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
03/07/2000 | US6033872 Polynucleotides encoding a novel human 11cb splice variant |
03/07/2000 | US6033661 Composition and method for allogenetic mononuclear cell immunotherapy |
03/07/2000 | US6033660 Method of treating a nervous system injury with cultured schwann cells |
03/07/2000 | US6032807 Methods for correlating average fiber diameter with performance in complex filtration media |
03/02/2000 | WO2000011202A1 Cationic complexes of polymer-modified adenovirus |
03/02/2000 | WO2000011201A1 Targeted alphavirus and alphaviral vectors |
03/02/2000 | WO2000011183A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
03/02/2000 | WO2000011139A1 Cell population containing non-fetal hemangioblasts and method for producing same |
03/02/2000 | WO2000011019A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agent |